Trial intelligence / Profile preview

N-Acetylcysteine in Infants Undergoing Arterial Switch Procedure

NCT00374088Phase 2Completed

Sponsor
University of Michigan
Start
Feb 2005
Primary completion
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in myocardial dysfunction comparing N-Acetylcysteine with Placebo (2 arms). Primary endpoint: Maximum Decline in Measured Cardiac Output at 24 hours. Started Feb 2005; status: completed.

02

Drugs

acetylcysteine
03

Conditions

myocardial dysfunction

Beyond the preview

Go deeper on NCT00374088.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00374088.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call